scholarly journals Phase I dose-escalation trial investigating volasertib as monotherapy or in combination with cytarabine in patients with relapsed/refractory acute myeloid leukaemia

2018 ◽  
Vol 184 (6) ◽  
pp. 1018-1021 ◽  
Author(s):  
Oliver G. Ottmann ◽  
Carsten Müller-Tidow ◽  
Alwin Krämer ◽  
Richard F. Schlenk ◽  
Michael Lübbert ◽  
...  
Keyword(s):  
Acute Myeloid Leukaemia ◽  
Phase I ◽  
Myeloid Leukaemia ◽  
Dose Escalation ◽  
Acute Myeloid

Phase I-II study of aclarubicin for treatment of acute myeloid leukaemia

2009 ◽  
Vol 38 (S47) ◽  
pp. 33-42
Author(s):  
David Machover ◽  
Julio Gastiaburu ◽  
Michel Delgado ◽  
Emma Goldschmidt ◽  
Manuel Benavides ◽  
...  
Keyword(s):  
Acute Myeloid Leukaemia ◽  
Phase I ◽  
Myeloid Leukaemia ◽  
Acute Myeloid

scholarly journals A phase I/II study of sunitinib and intensive chemotherapy in patients over 60 years of age with acute myeloid leukaemia and activatingFLT3mutations

2015 ◽  
Vol 169 (5) ◽  
pp. 694-700 ◽  
Author(s):  
Walter Fiedler ◽  
Sabine Kayser ◽  
Maxim Kebenko ◽  
Melanie Janning ◽  
Jürgen Krauter ◽  
...  
Keyword(s):  
Acute Myeloid Leukaemia ◽  
Phase I ◽  
Myeloid Leukaemia ◽  
Intensive Chemotherapy ◽  
Acute Myeloid

scholarly journals Toll‐like receptor 7/8‐matured RNA‐transduced dendritic cells as post‐remission therapy in acute myeloid leukaemia: results of a phase I trial

2020 ◽  
Vol 9 (3) ◽  
Author(s):  
Felix S Lichtenegger ◽  
Frauke M Schnorfeil ◽  
Maurine Rothe ◽  
Katrin Deiser ◽  
Torben Altmann ◽  
...  
Keyword(s):  
Dendritic Cells ◽  
Acute Myeloid Leukaemia ◽  
Phase I ◽  
Myeloid Leukaemia ◽  
Phase I Trial ◽  
Toll Like Receptor ◽  
Acute Myeloid
Sign in / Sign up

Export Citation Format

Share Document